Research ArticleArticle
Alpha-Amylase Inhibitor, CS-1036 Binds to Serum Amylase in a Concentration-Dependent and Saturable Manner
Tomohiro Honda, Yoko Kaneno-Urasaki, Takashi Ito, Takako Kimura, Nobuko Matsushima, Hiromi Okabe, Atsushi Yamasaki and Takashi Izumi
Drug Metabolism and Disposition March 2014, 42 (3) 326-333; DOI: https://doi.org/10.1124/dmd.113.054452
Tomohiro Honda
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Yoko Kaneno-Urasaki
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Takashi Ito
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Takako Kimura
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Nobuko Matsushima
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Hiromi Okabe
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Atsushi Yamasaki
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
Takashi Izumi
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.H., Y.K.-U., T.It., T.Iz.); Medicinal Chemistry Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (T.K.); Translational Medicine & Clinical Pharmacology Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (N.M., H.O.); and Global Project Management Department, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan (A.Y.)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
CS-1036 Binds to Serum Amylase
Tomohiro Honda, Yoko Kaneno-Urasaki, Takashi Ito, Takako Kimura, Nobuko Matsushima, Hiromi Okabe, Atsushi Yamasaki and Takashi Izumi
Drug Metabolism and Disposition March 1, 2014, 42 (3) 326-333; DOI: https://doi.org/10.1124/dmd.113.054452
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement